PFIZER INC Proceeds from Divestiture of Businesses
PFIZER INC (PFE) had Proceeds from Divestiture of Businesses of $300.00 million as of 2023-09-19, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2026-02-26
- PFIZER INC proceeds from divestiture of businesses for the quarter ending 2012-12-31 was $11.85B.
- PFIZER INC proceeds from divestiture of businesses for the quarter ending 2011-12-31 was $0.00.
- PFIZER INC proceeds from divestiture of businesses for fiscal 2014 was $0.00.
- PFIZER INC proceeds from divestiture of businesses for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- PFIZER INC proceeds from divestiture of businesses for fiscal 2012 was $11.85B, a 398.74% increase from fiscal 2011.
- PFIZER INC proceeds from divestiture of businesses for fiscal 2011 was $2.38B.
| Period end | Proceeds from Divestiture of Businesses | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|
| 2023-09-19 | $300.00M 10-K · filed 2026-02-26 | |||
| 2014-12-31 | $0.00 10-K · filed 2015-02-27 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 | |||
| 2012-12-31 | $11.85B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $11.85B 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.38B 10-K · filed 2014-02-28 | ||
| 2011-10-02 | $2.38B 10-Q · filed 2012-11-09 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |